MESO Relative Valuation
MESO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MESO is overvalued; if below, it's undervalued.
Historical Valuation
Mesoblast Ltd (MESO) is now in the Undervalued zone, suggesting that its current forward PS ratio of 28.91 is considered Undervalued compared with the five-year average of -10.81. The fair price of Mesoblast Ltd (MESO) is between 103.02 to 115.38 according to relative valuation methord. Compared to the current price of 12.34 USD , Mesoblast Ltd is Undervalued By 88.02%.
Relative Value
Fair Zone
103.02-115.38
Current Price：12.34
88.02%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
3.73
P/B
Median3y
7.13
Median5y
4.98
-2.87
FCF Yield
Median3y
-13.04
Median5y
-12.09
Competitors Valuation Multiple
The average P/S ratio for MESO's competitors is 1050.83, providing a benchmark for relative valuation. Mesoblast Ltd Corp (MESO) exhibits a P/S ratio of 30.61, which is -97.09% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Mesoblast Ltd (MESO) currently overvalued or undervalued?
What is Mesoblast Ltd (MESO) fair value?
How does MESO's valuation metrics compare to the industry average?
What is the current P/B ratio for Mesoblast Ltd (MESO) as of Jul 19 2025?
What is the current FCF Yield for Mesoblast Ltd (MESO) as of Jul 19 2025?
What is the current Forward P/E ratio for Mesoblast Ltd (MESO) as of Jul 19 2025?